Master Drug Discovery and Development (606)

MPS1 Einführung in Drug Discovery und Preclinical Drug Development (8 ECTS)

• 323001 VU 5 ECTS [ en ] Introduction to Drug Discovery and Preclinical Drug Development - MPS1
  Langer
• 323002 UE 3 ECTS [ en ] Introduction to Experimental Methods in Drug Discovery and Preclinical Drug Development - MPS1
  Zotchev

MPS2 Grundlagen der Arzneistoffentwicklung (8 ECTS)

MPS3 Drug Discovery (7 ECTS)

MPS4 Preclinical Drug Development (7 ECTS)

MPS5 Advanced Methods in Drug Discovery and Preclinical Drug Development (15 ECTS)

• 322054 VO 1 ECTS [ en ] Human Gene Therapy: From basics to clinical applications - M14
  Ogris
• 323101 VU 2 ECTS [ en ] Pharmacoinformatics - MPS5
  Ecker, Mo 08:00-11:15 (2×), Mi 13.03. 08:00-11:15, Do 14.03. 08:00-11:15
• 323102 VU 4 ECTS [ en ] Pharmacoinformatics Practical Course - MPS5
  Ecker
• 323104 VU 2 ECTS [ en ] Biophysics in Drug Discovery - MPS5
  Rademacher
• 323105 VU 2 ECTS [ en ] Innovation & Leadership in Preclinical Drug Development - MPS5
  Bryant, Mo 16:45-18:45 (3×), Di 16:45-18:45 (3×), Mi 16:45-18:45 (3×), Do 16:45-18:45 (2×), Di 23.04. 16:45-19:15, Do 25.04. 17:00-20:00
• 323114 VU 2 ECTS [ en ] The path from bench to bedside - a regulatory view - MPS5
  Pichler
• 323115 VU 2 ECTS [ en ] NMR for Drug Design - MPS5
  Orts

MPS6 Experimental Methods in Drug Discovery und Preclinical Drug Development (10 ECTS)

• 323007 UE 10 ECTS [ en ] Experimental Methods in Drug Discovery und Preclinical Drug Development - MPS6 - (2 Courses)
  Rollinger

MPS7 Case Studies in Drug Discovery und Preclinical Drug Development (5 ECTS)

• 323008 SE 5 ECTS [ en ] Case Studies in Drug Discovery and Preclinical Drug Development - MPS7 - (2 Courses)
  Langer, Di 04.06. 14:00-16:30, Mo 10.06. 09:00-11:30

MPS8 Forschungspraktikum (20 ECTS)

MPS9 Verfassen eines Forschungsantrages (5 ECTS)

MPS10 Zusatzqualifikation und wissenschaftliche Vertiefung (5 ECTS)

• 323151 VU 2 ECTS [ en ] Fragment-based Drug Design - MPS10
  Rademacher